ScholarLens Back to search
2005•Unpublished venueRequires access

The Role of Somatostatin in the Treatment of Early Postoperative Inflammatory Intestinal Obstruction

Zhongyue Chen

Open publisher page 0 citations

Abstract

[Objective]To evaluate the role of somatostatin in the treatment of early postoperative inflammatory intestinal obstruction.[Methods]The clinical data of 55 cases of early postoperative inflammatory intestinal obstruction treated at our hospital from January, 2000 to May, 2005 were analyzed retrospectively. Of them, 18 patients(control group) were treated by routine conservative method,the other 37 patients(test group) by somatostatin combined with other conservative method,then the cure times were compared. [Results] The cure time in test group was 5~20 days, averaged (15.2±8) days. that in control group was 8~40 days,averaged (20.2±11) days.the cure time in test group was shorter than in control group significantly.[Conclusion]Somatostatin has better curative effect in the patients with early postoperative inflammatory intestinal obstruction.

About this research paper

What this paper is about

[Objective]To evaluate the role of somatostatin in the treatment of early postoperative inflammatory intestinal obstruction.[Methods]The clinical data of 55 cases of early postoperative inflammatory intestinal obstruction treated at our hospital from January, 2000 to May, 2005 were analyzed retrospectively. Of them, 18 patients(control group) were treated by routine conservative method,the other 37 patients(test group) by somatostatin combined with other conservative method,then the cure times were compared. [Results] The cure time in test group was 5~20 days, averaged (15.2±8) days. that in control group was 8~40 days,averaged (20.2±11) days.the cure time in test group was shorter than in control group significantly.[Conclusion]Somatostatin has better curative effect in the patients with early postoperative inflammatory intestinal obstruction.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

[Objective]To evaluate the role of somatostatin in the treatment of early postoperative inflammatory intestinal obstruction.[Methods]The clinical data of 55 cases of early postoperative inflammatory intestinal obstruction treated at our hospital from January, 2000 to May, 2005 were analyzed retrospectively. Of them, 18 patients(control group) were treated by routine conservative method,the other 37 patients(test group) by somatostatin combined with other conservative method,then the cure times were compared. [Results] The cure time in test group was 5~20 days, averaged (15.2±8) days. that in control group was 8~40 days,averaged (20.2±11) days.the cure time in test group was shorter than in control group significantly.[Conclusion]Somatostatin has better curative effect in the patients with early postoperative inflammatory intestinal obstruction.

Key concepts: Somatostatin, Medicine, Surgery, Conservative treatment, Cure rate, Gastroenterology, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The Role of Somatostatin in the Treatment of Early Postoperative Inflammatory Intestinal Obstruction — Research Paper | ScholarLens